Reaction
Therapeutic Product Effect Increased reporting signals
As of the last recalculation, Therapeutic Product Effect Increased appears in 1,126 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is LINACLOTIDE (PRR 27.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Linaclotide | 38 | 27.2 | 27.2 |
| Lurasidone Hydrochloride | 30 | 27.2 | 27.2 |
| Esketamine Hydrochloride | 21 | 22.2 | 22.2 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 35 | 21.5 | 21.5 |
| Heparin Sodium | 14 | 19.0 | 19.1 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 8 | 18.2 | 18.2 |
| Rocuronium Bromide | 9 | 14.2 | 14.2 |
| Suvorexant | 9 | 12.9 | 12.9 |
| Testosterone Cypionate | 5 | 10.4 | 10.4 |
| Methylphenidate | 13 | 8.4 | 8.4 |